CORRECTED: Mylan's Inequitable Conduct Claim Axed In Vytorin IP Suit
Schering Corp. on Tuesday won the dismissal of an inequitable conduct counterclaim by Mylan Pharmaceuticals Inc. in a ruling in Schering's lawsuit accusing the generic-drug maker of infringing its patents on...To view the full article, register now.
Already a subscriber? Click here to view full article